Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Pignon

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Progression-free survival is a surrogate for survival in advanced colorectal cancerMarc Buyse, Tomasz Burzykowski, Kevin Carroll, et al.
Lancet (London, England)|July 22, 2014
Preoperative chemotherapy for non-small-cell lung cancer--authors' replySarah Burdett, Larysa H M Rydzewska, Jayne F Tierney, et al.
The Lancet. Oncology|October 19, 2007
Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient dataKarim Fizazi, Aurelie Le Maitre, Gary Hudes, et al.
Cancer Treatment and Research Communications|December 24, 2022
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatmentEugénie Rigault, Benjamin Lacas, Olivier Glehen, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic valueFrancesco Facchinetti, Maria Virginia Bluthgen, Gabrielle Tergemina-Clain, et al.
BMC Cancer|August 8, 2018
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973)Diane Goéré, Jean-Pierre Pignon, Maximiliano Gelli, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2011
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancerBenjamin Besse, David Planchard, Anne-Sophie Veillard, et al.
Radiation Oncology (London, England)|September 28, 2011
Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survivalLucie Oberic, Frédéric Viret, Charlotte Baey, et al.
BMJ Open|March 15, 2013
Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trialsSilvy Laporte, Pierre Squifflet, Noémie Baroux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient dataJean Bourhis, Pierre Blanchard, Emilie Maillard, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Progression-free survival is a surrogate for survival in advanced colorectal cancerMarc Buyse, Tomasz Burzykowski, Kevin Carroll, et al.
Lancet (London, England)|July 22, 2014
Preoperative chemotherapy for non-small-cell lung cancer--authors' replySarah Burdett, Larysa H M Rydzewska, Jayne F Tierney, et al.
The Lancet. Oncology|October 19, 2007
Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient dataKarim Fizazi, Aurelie Le Maitre, Gary Hudes, et al.
Cancer Treatment and Research Communications|December 24, 2022
Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatmentEugénie Rigault, Benjamin Lacas, Olivier Glehen, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
LKB1/STK11 mutations in non-small cell lung cancer patients: Descriptive analysis and prognostic valueFrancesco Facchinetti, Maria Virginia Bluthgen, Gabrielle Tergemina-Clain, et al.
BMC Cancer|August 8, 2018
Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973)Diane Goéré, Jean-Pierre Pignon, Maximiliano Gelli, et al.
Lung Cancer (Amsterdam, Netherlands)|December 22, 2011
Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancerBenjamin Besse, David Planchard, Anne-Sophie Veillard, et al.
Radiation Oncology (London, England)|September 28, 2011
Docetaxel- and 5-FU-concurrent radiotherapy in patients presenting unresectable locally advanced pancreatic cancer: a FNCLCC-ACCORD/0201 randomized phase II trial's pre-planned analysis and case report of a 5.5-year disease-free survivalLucie Oberic, Frédéric Viret, Charlotte Baey, et al.
BMJ Open|March 15, 2013
Prediction of survival benefits from progression-free survival benefits in advanced non-small-cell lung cancer: evidence from a meta-analysis of 2334 patients from 5 randomised trialsSilvy Laporte, Pierre Squifflet, Noémie Baroux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2011
Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient dataJean Bourhis, Pierre Blanchard, Emilie Maillard, et al.
Pageof 15